Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)

What Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) does

RC2NB is a non-profit, university-affiliated clinical research organization established in 2019 and headquartered in Basel, Switzerland, with a stated focus on clinical neuroimmunology and neuroscience. The center operates with a small team of 13 employees and is digitally domiciled under the University of Basel's domain (rc2nb.unibas.ch), indicating an institutional affiliation with that academic medical environment rather than an independent commercial entity.

The organization's core activity is disease-oriented research at the intersection of neuroimmunology and clinical neuroscience — a domain that typically encompasses translational studies of neuroinflammatory conditions, biomarker identification, and clinical characterization of neurological disorders. There is no commercial product portfolio, no disclosed intellectual property holdings, and no named industry partners, customers, or research collaborations in the source data. The technical platform, methodology stack, and current research pipeline are not described in the available input.

From a business-model standpoint, RC2NB operates as a non-profit research center, which implies funding through academic grants, institutional support from the University of Basel, and potentially competitive public or philanthropic funding streams rather than commercial revenue. No pricing model, GTM motion, customer segments, or revenue figures are disclosed. Operating status, ownership structure, financials, and detailed operational information could not be confirmed from the source data, as the primary commercial domain (rc2nb.ch) renders only a verification/loading page with no substantive organizational detail.

Name

Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)

Legal name

Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)

Website

https://rc2nb.unibas.ch

Company type

Private

Headcount range

11–50 employees

Short description

RC2NB is a small (13-employee) non-profit clinical research center founded in 2019 in Basel, Switzerland, affiliated with the University of Basel, focused on translational research at the intersection of clinical neuroimmunology and neuroscience.

Ownership category

akta.pro rank

Product category

Clinical Neuroimmunology and Neuroscience Research

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAGAEAA

Central Laboratory Services (Core Lab Operations)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

• Clinical neuroimmunology research
• Neuroscience research services
• Translational neurology research
• Clinical research services
• Neuroimmunology studies

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Core offering

RC2NB is a clinical neuroimmunology and neuroscience research center based in Basel, Switzerland, affiliated with the University of Basel. It conducts clinical and translational research focused on neurological diseases and the role of the immune system in the nervous system. Detailed product or service offerings are not documented in the available source material.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Novartis: Swiss multinational pharmaceutical company headquartered in Basel with significant neuroscience research operations. Could partner with or compete for talent against RC2NB, and operates the affiliated Friedrich Miescher Institute in Basel.
• Bio-Techne: US-based biotechnology company providing research reagents and tools widely used in neuroscience and immunology research. Comparable as an enabling organization in the neuroscience research ecosystem that supplies technologies to research centers like RC2NB.
• Biogen: US-based biotechnology company with major focus on neuroimmunology and multiple sclerosis therapeutics. Comparable as a research-driven organization centered on neuroimmunology, representing the commercial translation of academic discoveries in this field.
• Eurofins Scientific: Luxembourg-headquartered contract research organization providing clinical diagnostics and research testing services. Comparable as a life sciences research services provider operating in the European neuroscience and immunology testing market.
• Charles River Laboratories: US-based contract research organization providing preclinical and clinical research services, including neuroscience research support. Comparable as a research services provider in the broader life sciences ecosystem that competes for similar research partnerships.
• Roche: Swiss multinational pharmaceutical company headquartered in Basel with major neuroscience and neuroimmunology drug development programs (including multiple sclerosis therapies). Comparable as a Basel-based organization operating in neuroimmunology R&D and a potential partner for translational research.

Direct peers

• Max Planck Institute for Multidisciplinary Sciences: German research institute with significant neuroimmunology and neuroscience research programs. Directly comparable as a research-focused institution generating peer-reviewed neuroscience discoveries, though at much larger scale.
• Allen Institute for Brain Science: US-based non-profit neuroscience research institute producing large-scale brain research. Comparable as a focused neuroscience research center generating field-defining discoveries, though with substantially larger resources.
• Karolinska Institutet - Department of Clinical Neuroscience: Swedish medical university with major clinical neuroscience and neuroimmunology research programs. Comparable as an academic research center focused on clinical neuroscience with translational impact.

Regional players

• Friedrich Miescher Institute for Biomedical Research: Basel-based biomedical research institute affiliated with the Novartis Research Foundation. Comparable as a Basel-region research institution operating in adjacent biomedical research areas with similar funding and talent dynamics.

Market position

Strengths4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/research-center-for-clinical-neuroimmunology-and-neuroscience-basel-rc2nb

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)